Search for: "Hikma Pharmaceuticals USA Inc" Results 1 - 20 of 24
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Dec 2019, 9:59 pm by Patent Docs
By Donald Zuhn -- On Friday, the United States filed its brief in response to the March 18, 2019 order of the Supreme Court inviting the Solicitor General to express the views of the United States on the petition for certiorari filed by Petitioners Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Ltd. in Hikma Pharmaceuticals USA Inc. v. [read post]
27 Feb 2019, 4:14 pm by Dennis Crouch
by Dennis Crouch Hikma Pharmaceuticals USA Inc. v. [read post]
Voting after Friday’s conference, the Supreme Court followed the Solicitor General’s advice and denied certiorari in Hikma Pharmaceuticals USA Inc. v. [read post]
13 Jan 2020, 9:11 pm by Patent Docs
Mayo Collaborative Services, LLC; Hikma Pharmaceuticals USA Inc. v. [read post]
18 Mar 2019, 9:56 am by Dennis Crouch
by Dennis Crouch Hikma Pharmaceuticals USA Inc., et al. v. [read post]
7 Jun 2021, 6:55 am by Dennis Crouch
Hikma Pharmaceuticals USA Inc., No. 20-1119; Attorney Fees: Roadie, Inc. v. [read post]
30 Mar 2020, 10:00 pm
Hikma Pharmaceuticals USA Inc., regarding the validity of six patents owned by Amarin Pharmaceuticals for the drug Vascepa. [read post]
29 Jul 2021, 11:02 am by Dennis Crouch
Hikma Pharmaceuticals USA Inc., Docket No. 21-02024 (Fed. [read post]
19 Jun 2019, 6:18 am by Dennis Crouch
Berkheimer, No. 18-415 (fact-law divide in eligibility); Hikma Pharmaceuticals USA Inc., et al. v. [read post]
8 Feb 2019, 9:45 am by Aurora Barnes
Hikma Pharmaceuticals USA Inc. v. [read post]
13 Mar 2019, 9:10 am by Dennis Crouch
Hikma Pharmaceuticals USA Inc., et al. v. [read post]
8 Oct 2019, 9:44 am by Dennis Crouch
Berkheimer, No. 18-415 (fact-law divide in eligibility) (waiting for views of Solicitor General) Hikma Pharmaceuticals USA Inc., et al. v. [read post]